mitogenic


Also found in: Dictionary, Thesaurus, Encyclopedia.

mi·to·gen·ic

(mī'tō-jen'ik),
Causing mitosis or transformation.

mi·to·gen·ic

(mī-tō-jen'ik)
Causing mitosis or transformation.
References in periodicals archive ?
Besides, HEJFP induced mitogenic activity of fibroblasts, an important feature in the wound healing process.
Patients who routinely engage in such protocols (typically twice a day), show significant immuno-modulation activity with increased T-cell responsiveness, mitogenic stimulation of raised titres of IgM and IgG antibody production, enhanced NK cell activity and elevated interleukin 2 levels.
RE-021 was formerly known as DARA (a Dual Acting Receptor Antagonist of Angiotensin and Endothelin) and possesses two clinically validated mechanisms of action that selectively block two potent vasoconstrictor and mitogenic agents, angiotensin II and endothelin 1, at their respective receptors.
Insulin has known mitogenic properties [7] and the stimulation of this hormone could have assisted in the formation of the breast tissue.
This mitogenic effect probably explains the characteristic BALT hyperplasia observed in infected host tissues.
Adenosine deaminase can stimulate mitogenic and prosurvival actions by controlling Mitotic-Activated Protein Kinase (MAPK) family of kinases.
D'Angelo G, Lee H, Weiner RI: cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in .
Birds raised on non-GD and GD-used litter had greater spleen cell mitogenic responses compared with chickens raised on fresh litter.
Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.
20) Intracellular GSH is also required for the T-cell proliferative response to mitogenic stimulation, for the activation of cytotoxic T "killer" cells, (21) and for many specific T-cell functions, including DNA synthesis for cell replication, as well as for the metabolism of interleukin-2 (IL-2), which is important for the mitogenic response.
On the other hand, Fortier (2009), stated that one of the primary disadvantages of PRP therapy is the lack of stem cells within its preparation; though, in spite of this, in vitro studies done in humans have demonstrated the mitogenic stimulation of mesenchymal stem cells (hMSCs) by releasing PRP, taking him to the conclusion that approximately 90% of the mitogenic activity in PRP is derived by the release of platelet (Haynesworth et al.
6 This mechanism leads to adown regulation of cellular proliferation and release of mitogenic agents from the newly formed conjunctival fibroblasts, thereby inhibiting the growth of the conjunctival tissue.